Copyright
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Jan 16, 2022; 14(1): 35-48
Published online Jan 16, 2022. doi: 10.4253/wjge.v14.i1.35
Published online Jan 16, 2022. doi: 10.4253/wjge.v14.i1.35
Current role of endoscopic ultrasound in the diagnosis and management of pancreatic cancer
Federico Salom, Department of Gastroenterology, Hospital Mexico, Uruca 1641-2050, San Jose, Costa Rica
Frédéric Prat, Servide d'Endoscopie, Hopital Beaujon, Université Paris et INSERM U1016, Clichy 92118, Paris, France
Author contributions: Salom F was responsible for the preparation of the manuscript; Prat F was responsible for revising and final approval of the article; all authors agree with the final version of this manuscript.
Conflict-of-interest statement: The authors of this manuscript have no conflicts of interest to disclose.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work noncommercially, and license their derivative works on different terms, provided the original work is properly cited and the use is noncommercial. See: http://creativecommons.org/Licenses/bync/4.0/
Corresponding author: Federico Salom, MD, Medical Assistant, Department of Gast
Received: May 5, 2021
Peer-review started: May 5, 2021
First decision: June 17, 2021
Revised: July 3, 2021
Accepted: December 21, 2021
Article in press: December 21, 2021
Published online: January 16, 2022
Processing time: 253 Days and 0.4 Hours
Peer-review started: May 5, 2021
First decision: June 17, 2021
Revised: July 3, 2021
Accepted: December 21, 2021
Article in press: December 21, 2021
Published online: January 16, 2022
Processing time: 253 Days and 0.4 Hours
Core Tip
Core Tip: Endoscopic ultrasound (EUS) is currently an essential tool in the diagnostic work-up and treatment of pancreatic cancer. Contrast-enhanced harmonics, elastography and artificial intelligence provide additional information in the evaluation of focal pancreatic lesions to improve diagnostic accuracy during EUS evaluation. Interventional EUS has dramatically improved the palliative treatment of patients with pancreatic cancer, basically for local ablation therapies, adequate pain control with celiac plexus neurolysis and EUS-guided biliary drainage for the treatment of biliary obstruction.